Hibah Khaja, PharmD

All articles by Hibah Khaja, PharmD

Risk Factors for MACE and Malignancies Among Patients Treated With Tofacitinib vs TNF Inhibitors

July 20, 2023

Investigators conducted a post hoc analysis to determine the relative risks for major adverse cardiovascular events and malignancies among certain subpopulations when treated with tofacitinib vs tumor necrosis factor inhibitors.

Rheumatology

JAK Inhibitors Associated With Higher Incidence of Malignancy vs TNF Inhibitors

Hibah Khaja, PharmD

July 14, 2023

Investigators assessed the association between JAK inhibitors and malignancy incidence, compared with placebo, methotrexate, and TNF inhibitors.

Rheumatology

Increased Burden of Psychiatric Morbidity in Patients With Juvenile Idiopathic Arthritis

Hibah Khaja, PharmD

June 22, 2023

The incidence and burden of psychiatric disorders in juvenile idiopathic arthritis were studied.

Next post in Rheumatology

Hibah Khaja, PharmD

All articles by Hibah Khaja, PharmD

Risk Factors for MACE and Malignancies Among Patients Treated With Tofacitinib vs TNF Inhibitors

JAK Inhibitors Associated With Higher Incidence of Malignancy vs TNF Inhibitors

Increased Burden of Psychiatric Morbidity in Patients With Juvenile Idiopathic Arthritis

Incidence of Gout Increased Globally Among Young Individuals From 1990 to 2019